[Acute drug allergic thrombocytopenia caused by antazoline].
D000368:Aged; D000404:Ajmaline / Q000627:therapeutic use; D000814:Aniline Compounds / Q000009:adverse effects; D001145:Arrhythmias, Cardiac / Q000188:drug therapy; D001593:Benzyl Compounds / Q000009:adverse effects; D001856:Bone Marrow Examination; D002470:Cell Survival; D002860:Chromium Radioisotopes; D003018:Clot Retraction; D004077:Digoxin / Q000627:therapeutic use; D004338:Drug Combinations; D004342:Drug Hypersensitivity / Q000276:immunology; D005029:Ethylenediamines / Q000627:therapeutic use; D006651:Histocytochemistry; D006801:Humans; D007093:Imidazoles / Q000009:adverse effects*; D008297:Male; D008533:Megakaryocytes; D010634:Phenobarbital / Q000627:therapeutic use; D013034:Sparteine / Q000627:therapeutic use; D013921:Thrombocytopenia / Q000139:chemically induced*
D000814:Aniline Compounds; D001593:Benzyl Compounds; D002860:Chromium Radioisotopes; D004338:Drug Combinations; D005029:Ethylenediamines; D007093:Imidazoles; D000404:Ajmaline; D013034:Sparteine; D004077:Digoxin; D010634:Phenobarbital
Akute medikamentös-allergische Thrombozytopenie durch Antazolin